NaNose Medical
Osnat Sella-Tavor is an experienced Chief Technology Officer with a background in managing interdisciplinary research and development projects in the field of innovative technologies for gastrointestinal diagnostics. With a strong educational foundation in Molecular Biology and extensive experience in positions such as Research Manager and Project Manager, Osnat has successfully led teams of experts from various fields to achieve groundbreaking results. Responsibilities include setting work plans, identifying collaborators, advancing technologies into clinical studies, patent applications, budget planning, and presenting to senior management.
This person is not in any teams
This person is not in any offices
NaNose Medical
Nanose Medical electronic nose is based on innovative smart sensor array developed by Prof Haick at the Technion. The sensors respond to Volatile Organic Compounds (VOCs) emitted in the exhaled breath, which are biomarkers for a variety of diseases. Artificial Intelligence analyses the sensor array signal pattern to detect the unique “signal print" for each disease. Nanose cutting edge technology will enable inexpensive hand-held diagnostic device for effortless, non-invasive and affordable breath test for remote & objective screening, diagnosis and monitoring of a variety of diseases. Nanose Medical device will enable to tailor care for individual patients while offering significant savings to healthcare providers by improved telemedicine and reduced number of avoidable cumbersome tests. Nanose products will revolutionize healthcare by providing a 21st century technology that is cost effective, friendly, and safe.